Article
Molecular Biomarkers in Neurological Diseases: Advances in Diagnosis and Prognosis
2025-02-10
Abstract excerpt
<h4>Background: </h4> Neurological diseases contribute significantly to disability and mortality, necessitating improved diagnostic and prognostic tools. Advances in molecular biomarkers at genomic, transcriptomic, epigenomic, and proteomic levels have facilitated early disease detection. Notably, neurofilament light chain (NfL) serves as a key biomarker of neurodegeneration, while liquid biopsy techniques enable...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 38227df8-1c4a-5d55-9445-8ee04a04f74d
- DOI
- 10.20944/preprints202502.0647.v1
